Filing Details
- Accession Number:
- 0000899140-24-001286
- Form Type:
- 4
- Zero Holdings:
- No
- Publication Time:
- 2024-11-18 20:37:32
- Reporting Period:
- 2024-11-14
- Accepted Time:
- 2024-11-18 20:37:32
- SEC Url:
- Form 4 Filing
Issuer
| Cik | Name | Symbol | Sector (SIC) | IRS No |
|---|---|---|---|---|
| 1410098 | Cormedix Inc. | CRMD | Pharmaceutical Preparations (2834) | 000000000 |
Insiders
| Cik | Name | Reported Address | Insider Title | Director | Officer | Large Shareholder | Other |
|---|---|---|---|---|---|---|---|
| 1735256 | Elizabeth Hurlburt | C/O Cormedix Inc. 300 Connell Drive, Suite 4200 Berkeley Heights NJ 07922 | Evp | No | No | No | No |
Reported Non-Derivative Transactions
| Sec. Name | Acquisiton - Disposition | Date | Amount | Price | Remaning Holdings | Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
|---|---|---|---|---|---|---|---|---|---|---|
| Common Stock | Acquisiton | 2024-11-14 | 3 | $1.45 | 45,400 | No | 4 | M | Direct | |
| Common Stock | Acquisiton | 2024-11-14 | 8,169 | $8.30 | 53,569 | No | 4 | M | Direct | |
| Common Stock | Acquisiton | 2024-11-14 | 9,888 | $5.63 | 63,457 | No | 4 | M | Direct | |
| Common Stock | Acquisiton | 2024-11-14 | 34,467 | $4.08 | 97,924 | No | 4 | M | Direct | |
| Common Stock | Acquisiton | 2024-11-14 | 62,500 | $4.43 | 160,424 | No | 4 | M | Direct | |
| Common Stock | Acquisiton | 2024-11-14 | 25,000 | $3.47 | 185,424 | No | 4 | M | Direct | |
| Common Stock | Disposition | 2024-11-14 | 140,027 | $11.18 | 45,397 | No | 4 | S | Direct |
| Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
|---|---|---|---|---|
| No | 4 | M | Direct | |
| No | 4 | M | Direct | |
| No | 4 | M | Direct | |
| No | 4 | M | Direct | |
| No | 4 | M | Direct | |
| No | 4 | M | Direct | |
| No | 4 | S | Direct |
Reported Derivative Transactions
| Sec. Name | Sec. Type | Acquisiton - Disposition | Date | Amount | Price | Amount - 2 | Price - 2 |
|---|---|---|---|---|---|---|---|
| Common Stock | Stock Option (Right to Buy Common Stock) | Disposition | 2024-11-14 | 3 | $0.00 | 3 | $1.45 |
| Common Stock | Stock Option (Right to Buy Common Stock) | Disposition | 2024-11-14 | 8,169 | $0.00 | 8,169 | $8.30 |
| Common Stock | Stock Option (Right to Buy Common Stock) | Disposition | 2024-11-14 | 9,888 | $0.00 | 9,888 | $5.63 |
| Common Stock | Stock Option (Right to Buy Common Stock) | Disposition | 2024-11-14 | 34,467 | $0.00 | 34,467 | $4.08 |
| Common Stock | Stock Option (Right to Buy Common Stock) | Disposition | 2024-11-14 | 62,500 | $0.00 | 62,500 | $4.43 |
| Common Stock | Stock Option (Right to Buy Common Stock) | Disposition | 2024-11-14 | 25,000 | $0.00 | 25,000 | $3.47 |
| Remaning Holdings | Exercise Date | Expiration Date | Equity Swap Involved | Transaction Form Type | Transaction Code | Nature of Ownership |
|---|---|---|---|---|---|---|
| 53,997 | 2028-03-19 | No | 4 | M | Direct | |
| 12,711 | 2029-01-10 | No | 4 | M | Direct | |
| 27,612 | 2030-05-11 | No | 4 | M | Direct | |
| 3,033 | 2030-05-11 | No | 4 | M | Direct | |
| 62,500 | 2033-01-14 | No | 4 | M | Direct | |
| 75,000 | 2034-01-11 | No | 4 | M | Direct |
Footnotes
- This transaction was executed in multiple trades at prices ranging from $11.00 to $11.45. The price reported in Column 4 is a weighted average price. The reporting person hereby undertakes to provide upon request to the SEC staff, the Issuer or a security holder of the Issuer full information regarding the number of shares and prices at which the transactions were effected.
- These options were granted 3/19/2018 and vested as follows: 37,200 vested over four years in four (4) equal installments on the first four anniversaries of 3/19/2018. The remaining options vested on the achievement of certain milestones. This option was previously reported as covering 186,000 shares but was adjusted to reflect a reverse stock split that occurred on March 26, 2019.
- These options were granted 1/10/2019 and vested as follows: 35% of the options vest over time, with 25% vested on the grant date and 25% vesting on the first, second and third anniversaries of the grant date; and 65% of the options vest upon the achievement of certain milestones.
- These options were granted on 05/11/2020. These options vested 1/4 on the date of grant, 1/4 on the first anniversary of the date of grant, 1/4 on the second anniversary of the date of grant and 1/4 on the third anniversary of the date of grant.
- These options were granted on 05/11/2020. These options vested 1/4 on the date of grant, 1/4 on the first anniversary of the date of grant, 1/4 on the second anniversary of the date of grant and 1/4 on the third anniversary of the date of grant.
- These options were granted on 1/14/2023. These options vested 1/4 on the date of grant, 1/4 on the first anniversary of the date of grant and will vest 1/4 on the second anniversary of the date of grant and 1/4 on the third anniversary of the date of grant.
- These options were granted on 01/12/2024. These options vested 1/4 on the date of grant, and, subject to continued employment, will vest 1/4 on the first anniversary of the date of grant, 1/4 on the second anniversary of the date of grant and 1/4 on the third anniversary of the date of grant.
Billionaire Hedge Funds
